3D Printed Surgical Models Market Seen Reaching $2.4 Billion by 2033

By AI, Created 10:50 AM UTC, May 20, 2026, /AGP/ – Persistence Market Research projects the global 3D printed surgical models market will more than double by 2033 as hospitals adopt patient-specific planning tools and advanced imaging workflows. North America leads today, while Asia Pacific is expected to grow fastest as surgical demand and healthcare infrastructure expand.

Why it matters: - 3D printed surgical models are becoming a practical tool for precision medicine, helping surgeons plan complex procedures with more confidence. - Patient-specific models can reduce intraoperative uncertainty and support better surgical outcomes across cardiovascular, orthopedic, oncological and neurological care. - Aging populations are driving more surgeries, which increases demand for preoperative visualization and planning tools.

What happened: - Persistence Market Research estimated the global 3D printed surgical models market at US$ 927.5 million in 2026. - The market is projected to reach US$ 2,422.4 million by 2033. - The forecast implies a 14.7% compound annual growth rate from 2026 to 2033. - The report cites growing demand for clinical precision, personalized healthcare technologies and complex surgical planning. - The company also highlighted a free sample report and custom research offering: Download the sample report and request customization.

The details: - North America is projected to hold about 35% of the market in 2026. - Asia Pacific is expected to be the fastest-growing region from 2026 to 2033. - Cardiac surgery and interventional cardiology are projected to account for 37% of market share in 2026. - Neurosurgery is forecast to be the fastest-growing application because of demand for detailed models in complex brain and spine procedures. - Stereolithography is expected to hold 55% of the technology market in 2026. - Fused deposition modeling is projected to be the fastest-growing technology because of lower cost and broader accessibility. - Hospitals and ambulatory surgical centers are the main end users in the market segmentation. - Plastic and metal are listed as the key material categories. - The report segments the market by cardiac surgery/interventional cardiology, gastroenterology endoscopy of esophageal, neurosurgery, orthopedic surgery, reconstructive surgery, surgical oncology and transplant surgery. - The report names North America, Europe, East Asia, South Asia & Oceania, Latin America, and the Middle East & Africa as regional segments.

Between the lines: - The market is shifting from specialty use toward broader clinical adoption as imaging, segmentation software and additive manufacturing improve. - Integration of CT and MRI data into 3D workflows is shortening production timelines and improving diagnostic precision. - Multi-material printing, hybrid printing and new biomaterials are making models more realistic, which strengthens their value in simulation and implant selection. - High printer costs, custom production requirements and uneven reimbursement remain the main barriers to faster adoption. - Limited technical expertise and the need for coordination between radiology, engineering and surgery teams still slow implementation. - The competitive field is moderately fragmented, with companies differentiating through AI-enabled design, automation, clinical integration and material innovation. - The report lists Osteo3D, Axial3D, Lazarus 3D, Onkos Surgical, Formlabs, Materialise NV, 3D LifePrints U.K. Ltd. and WhiteClouds Inc. among key players.

What’s next: - Emerging healthcare markets could become a major growth engine as hospitals, surgical centers and diagnostic facilities expand. - Public investment, private-public partnerships and infrastructure modernization are expected to widen adoption. - Integration with digital health platforms, surgical simulation systems, augmented reality and AI-enabled tools should deepen clinical use. - Training programs and workflow standardization will likely become more important as adoption scales. - Recent university use cases in the U.S. suggest continued clinical experimentation, including work at the University of South Florida, Ohio State University and the University of Washington.

The bottom line: - The market is moving from a niche surgical planning aid into a broader precision-care platform, with growth led by imaging, automation and patient-specific medicine.